Histone acetylation and chromatin signature in stem cell identity and cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 637, Issue 1-2, 2008, Pages 1-15

  Shukla, Vivek ^a,b   Vaissière, Thomas ^a   Herceg, Zdenko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cancer; Chromatin modifications; Epigenetic mechanisms; Histone acetylation; Histone acetyltransferases; Stem and progenitor cells

Indexed keywords

DNA; HISTONE ACETYLTRANSFERASE;

ACETYLATION; BROMODOMAIN; CANCER; CELL DIFFERENTIATION; CELL FATE; CHEMICAL MODIFICATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; ENZYME MECHANISM; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC DISORDER; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SHORT SURVEY; STEM CELL;

ACETYLATION; ANIMALS; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PLURIPOTENT STEM CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; STEM CELLS;

EID: 37249012497     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.07.012     Document Type: Short Survey

References (108)

1. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7 (2006) 21-33
2. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
3. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
4. Cowan C.A., Atienza J., Melton D.A., and Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (2005) 1369-1373
5. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
6. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., Schafer X., Lun Y., and Lemischka I.R. Dissecting self-renewal in stem cells with RNA interference. Nature 442 (2006) 533-538
7. Polyak K., and Hahn W.C. Roots and stems: stem cells in cancer. Nat. Med. 12 (2006) 296-300
8. Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., and Terzis A.J. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat. Rev. Cancer 5 (2005) 899-904
9. Grewal S.I., and Jia S. Heterochromatin revisited. Nat. Rev. Genet. 8 (2007) 35-46
10. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
11. Kurdistani S.K., and Grunstein M. Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 4 (2003) 276-284
12. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
13. Fyodorov D.V., and Kadonaga J.T. The many faces of chromatin remodeling: switching beyond transcription. Cell 106 (2001) 523-525
14. Carrozza M.J., Utley R.T., Workman J.L., and Cote J. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19 (2003) 321-329
15. Santos-Rosa H., and Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer 41 (2005) 2381-2402
16. Fischle W., Wang Y., and Allis C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15 (2003) 172-183
17. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000) 435-459
18. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., and Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84 (1996) 843-851
19. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., and Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382 (1996) 319-324
20. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
21. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384 (1996) 641-643
22. Mizzen C.A., Yang X.J., Kokubo T., Brownell J.E., Bannister A.J., Owen-Hughes T., Workman J., Wang L., Berger S.L., Kouzarides T., Nakatani Y., and Allis C.D. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87 (1996) 1261-1270
23. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucl. Acids Res. 32 (2004) 959-976
24. de la Cruz X., Lois S., Sanchez-Molina S., and Martinez-Balbas M.A. Do protein motifs read the histone code?. Bioessays 27 (2005) 164-175
25. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000) 1553-1577
26. Grant P.A., Duggan L., Cote J., Roberts S.M., Brownell J.E., Candau R., Ohba R., Owen-Hughes T., Allis C.D., Winston F., Berger S.L., and Workman J.L. Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev. 11 (1997) 1640-1650
27. Sterner D.E., Belotserkovskaya R., and Berger S.L. SALSA, a variant of yeast SAGA, contains truncated Spt7, which correlates with activated transcription. Proc. Natl. Acad. Sci. USA 99 (2002) 11622-11627
28. Pray-Grant M.G., Schieltz D., McMahon S.J., Wood J.M., Kennedy E.L., Cook R.G., Workman J.L., Yates III J.R., and Grant P.A. The novel SLIK histone acetyltransferase complex functions in the yeast retrograde response pathway. Mol. Cell Biol. 22 (2002) 8774-8786
29. Zhang Y., and Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15 (2001) 2343-2360
30. Nightingale K.P., O'Neill L.P., and Turner B.M. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr. Opin. Genet Dev. 16 (2006) 125-136
31. Herceg Z., and Wang Z.Q. Rendez-vous at mitosis: TRRAPed in the chromatin. Cell Cycle 4 (2005) 383-387
32. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., and Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399 (1999) 491-496
33. Hassan A.H., Prochasson P., Neely K.E., Galasinski S.C., Chandy M., Carrozza M.J., and Workman J.L. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111 (2002) 369-379
34. Fernandez P.C., Frank S.R., Wang L., Schroeder M., Liu S., Greene J., Cocito A., and Amati B. Genomic targets of the human c-Myc protein. Genes Dev. 17 (2003) 1115-1129
35. Jeanmougin F., Wurtz J.M., Le Douarin B., Chambon P., and Losson R. The bromodomain revisited. Trends Biochem. Sci. 22 (1997) 151-153
36. Tamkun J.W., Deuring R., Scott M.P., Kissinger M., Pattatucci A.M., Kaufman T.C., and Kennison J.A. brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68 (1992) 561-572
37. Horn P.J., and Peterson C.L. The bromodomain: a regulator of ATP-dependent chromatin remodeling?. Front Biosci. 6 (2001) D1019-D1023
38. Winston F., and Allis C.D. The bromodomain: a chromatin-targeting module?. Nat. Struct. Biol. 6 (1999) 601-604
39. Bottomley M.J. Structures of protein domains that create or recognize histone modifications. EMBO Rep. 5 (2004) 464-469
40. Owen D.J., Ornaghi P., Yang J.C., Lowe N., Evans P.R., Ballario P., Neuhaus D., Filetici P., and Travers A.A. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 19 (2000) 6141-6149
41. Jacobson R.H., Ladurner A.G., King D.S., and Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science 288 (2000) 1422-1425
42. Myers F.A., Evans D.R., Clayton A.L., Thorne A.W., and Crane-Robinson C. Targeted and extended acetylation of histones H4 and H3 at active and inactive genes in chicken embryo erythrocytes. J. Biol. Chem. 276 (2001) 20197-20205
43. Bulger M. Hyperacetylated chromatin domains: lessons from heterochromatin. J. Biol. Chem. 280 (2005) 21689-21692
44. Vogelauer M., Wu J., Suka N., and Grunstein M. Global histone acetylation and deacetylation in yeast. Nature 408 (2000) 495-498
45. Eissenberg J.C., and Wallrath L.L. Heterochromatin, position effects, and the genetic dissection of chromatin. Prog. Nucl. Acid Res. Mol Biol. 74 (2003) 275-299
46. Rusche L.N., Kirchmaier A.L., and Rine J. The establishment, inheritance, and function of silenced chromatin in Saccharomyces cerevisiae. Annu. Rev. Biochem. 72 (2003) 481-516
47. Hebbes T.R., Clayton A.L., Thorne A.W., and Crane-Robinson C. Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J. 13 (1994) 1823-1830
48. Litt M.D., Simpson M., Recillas-Targa F., Prioleau M.N., and Felsenfeld G. Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J. 20 (2001) 2224-2235
49. Forsberg E.C., Downs K.M., Christensen H.M., Im H., Nuzzi P.A., and Bresnick E.H. Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc. Natl. Acad. Sci. USA 97 (2000) 14494-14499
50. Bulger M., Schubeler D., Bender M.A., Hamilton J., Farrell C.M., Hardison R.C., and Groudine M. A complex chromatin landscape revealed by patterns of nuclease sensitivity and histone modification within the mouse beta-globin locus. Mol. Cell Biol. 23 (2003) 5234-5244
51. Schubeler D., Groudine M., and Bender M.A. The murine beta-globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc. Natl. Acad. Sci. USA 98 (2001) 11432-11437
52. Anguita E., Johnson C.A., Wood W.G., Turner B.M., and Higgs D.R. Identification of a conserved erythroid specific domain of histone acetylation across the alpha-globin gene cluster. Proc. Natl. Acad. Sci. USA 98 (2001) 12114-12119
53. Bernstein B.E., Kamal M., Lindblad-Toh K., Bekiranov S., Bailey D.K., Huebert D.J., McMahon S., Karlsson E.K., Kulbokas III E.J., Gingeras T.R., Schreiber S.L., and Lander E.S. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120 (2005) 169-181
54. Chowdhury D., and Sen R. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20 (2001) 6394-6403
55. Masternak K., Peyraud N., Krawczyk M., Barras E., and Reith W. Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nat. Immunol. 4 (2003) 132-137
56. Zhou J., Ashouian N., Delepine M., Matsuda F., Chevillard C., Riblet R., Schildkraut C.L., and Birshtein B.K. The origin of a developmentally regulated Igh replicon is located near the border of regulatory domains for Igh replication and expression. Proc. Natl. Acad. Sci. USA 99 (2002) 13693-13698
57. Passarge E. Emil Heitz and the concept of heterochromatin: longitudinal chromosome differentiation was recognized fifty years ago. Am. J. Hum. Genet. 31 (1979) 106-115
58. Meaburn K.J., and Misteli T. Cell biology: chromosome territories. Nature 445 (2007) 379-781
59. Ebert A., Schotta G., Lein S., Kubicek S., Krauss V., Jenuwein T., and Reuter G. Su(var) genes regulate the balance between euchromatin and heterochromatin in Drosophila. Genes Dev. 18 (2004) 2973-2983
60. Horn P.J., and Peterson C.L. Heterochromatin assembly: a new twist on an old model. Chromosome Res. 14 (2006) 83-94
61. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., and Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
62. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., Berman D.M., Jenuwein T., Pruitt K., Sharkis S.J., Watkins D.N., Herman J.G., and Baylin S.B. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39 (2007) 237-242
63. Azuara V., Perry P., Sauer S., Spivakov M., Jorgensen H.F., John R.M., Gouti M., Casanova M., Warnes G., Merkenschlager M., and Fisher A.G. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8 (2006) 532-538
64. Perry P., Sauer S., Billon N., Richardson W.D., Spivakov M., Warnes G., Livesey F.J., Merkenschlager M., Fisher A.G., and Azuara V. A dynamic switch in the replication timing of key regulator genes in embryonic stem cells upon neural induction. Cell Cycle 3 (2004) 1645-1650
65. Vogelauer M., Rubbi L., Lucas I., Brewer B.J., and Grunstein M. Histone acetylation regulates the time of replication origin firing. Mol. Cell 10 (2002) 1223-1233
66. Lin C.M., Fu H., Martinovsky M., Bouhassira E., and Aladjem M.I. Dynamic alterations of replication timing in mammalian cells. Curr. Biol. 13 (2003) 1019-1028
67. Zhang J., Xu F., Hashimshony T., Keshet I., and Cedar H. Establishment of transcriptional competence in early and late S phase. Nature 420 (2002) 198-202
68. Pan G., and Thomson J.A. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 17 (2007) 42-49
69. Xiao L., Yuan X., and Sharkis S.J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24 (2006) 1476-1486
70. Sarma K., and Reinberg D. Histone variants meet their match. Nat. Rev. Mol. Cell Biol. 6 (2005) 139-149
71. Henikoff S., Furuyama T., and Ahmad K. Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet. 20 (2004) 320-326
72. Thiriet C., and Hayes J.J. Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell 18 (2005) 617-622
73. Phair R.D., Scaffidi P., Elbi C., Vecerova J., Dey A., Ozato K., Brown D.T., Hager G., Bustin M., and Misteli T. Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol. Cell Biol. 24 (2004) 6393-6402
74. Cheutin T., McNairn A.J., Jenuwein T., Gilbert D.M., Singh P.B., and Misteli T. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 299 (2003) 721-725
75. Festenstein R., Pagakis S.N., Hiragami K., Lyon D., Verreault A., Sekkali B., and Kioussis D. Modulation of heterochromatin protein 1 dynamics in primary Mammalian cells. Science 299 (2003) 719-721
76. Meshorer E., Yellajoshula D., George E., Scambler P.J., Brown D.T., and Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10 (2006) 105-116
77. Lee J.H., Hart S.R., and Skalnik D.G. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 38 (2004) 32-38
78. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., Bergman Y., Simon I., and Cedar H. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39 (2007) 232-236
79. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., Weisenberger D.J., Campan M., Young J., Jacobs I., and Laird P.W. Epigenetic stem cell signature in cancer. Nat. Genet. 39 (2007) 157-158
80. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., Wang W., Weng Z., Green R.D., Crawford G.E., and Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39 (2007) 311-318
81. Ringrose L., and Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38 (2004) 413-443
82. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., Koseki H., Fuchikami T., Abe K., Murray H.L., Zucker J.P., Yuan B., Bell G.W., Herbolsheimer E., Hannett N.M., Sun K., Odom D.T., Otte A.P., Volkert T.L., Bartel D.P., Melton D.A., Gifford D.K., Jaenisch R., and Young R.A. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125 (2006) 301-313
83. Cao R., and Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14 (2004) 155-164
84. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9 (2000) 2395-2402
85. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.M., Bollen M., Esteller M., Di Croce L., de Launoit Y., and Fuks F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439 (2006) 871-874
86. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
87. Herceg Z., Hulla W., Gell D., Cuenin C., Lleonart M., Jackson S., and Wang Z.Q. Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat. Genet. 29 (2001) 206-211
88. Loizou J.I., Murr R., Finkbeiner M.G., Sawan C., Wang Z.Q., and Herceg Z. Epigenetic information in chromatin: the code of entry for DNA repair. Cell Cycle 5 (2006) 696-701
89. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., and Cole M.D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94 (1998) 363-374
90. Wilson A., Murphy M.J., Oskarsson T., Kaloulis K., Bettess M.D., Oser G.M., Pasche A.C., Knabenhans C., Macdonald H.R., and Trumpp A. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18 (2004) 2747-2763
91. Bilodeau M., and Sauvageau G. Uncovering stemness. Nat. Cell Biol. 8 (2006) 1048-1049
92. Sparmann A., and van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6 (2006) 846-856
93. Allard S., Utley R.T., Savard J., Clarke A., Grant P., Brandl C.J., Pillus L., Workman J.L., and Cote J. NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J. 18 (1999) 5108-5119
94. Galarneau L., Nourani A., Boudreault A.A., Zhang Y., Heliot L., Allard S., Savard J., Lane W.S., Stillman D.J., and Cote J. Multiple links between the NuA4 histone acetyltransferase complex and epigenetic control of transcription. Mol. Cell 5 (2000) 927-937
95. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., and Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102 (2000) 463-473
96. Boudreault A.A., Cronier D., Selleck W., Lacoste N., Utley R.T., Allard S., Savard J., Lane W.S., Tan S., and Cote J. Yeast enhancer of polycomb defines global Esa1-dependent acetylation of chromatin. Genes Dev. 17 (2003) 1415-1428
97. Doyon Y., Selleck W., Lane W.S., Tan S., and Cote J. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol. Cell Biol. 24 (2004) 1884-1896
98. Ceol C.J., and Horvitz H.R. A new class of C. elegans synMuv genes implicates a Tip60/NuA4-like HAT complex as a negative regulator of Ras signaling. Dev. Cell 6 (2004) 563-576
99. Myzak M.C., and Dashwood R.H. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Lett. 233 (2006) 208-218
100. Marks P.A., Richon V.M., Kelly W.K., Chiao J.H., and Miller T. Histone deacetylase inhibitors: development as cancer therapy. Novartis Found Symp. 259 (2004) 269-281 discussion 281-268
101. Kelly W.K., Richon V.M., O'Connor O., Curley T., MacGregor-Curtelli B., Tong W., Klang M., Schwartz L., Richardson S., Rosa E., Drobnjak M., Cordon-Cordo C., Chiao J.H., Rifkind R., Marks P.A., and Scher H. Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. Clin. Cancer Res. 9 (2003) 3578-3588
102. Sandor V., Bakke S., Robey R.W., Kang M.H., Blagosklonny M.V., Bender J., Brooks R., Piekarz R.L., Tucker E., Figg W.D., Chan K.K., Goldspiel B., Fojo A.T., Balcerzak S.P., and Bates S.E. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin. Cancer Res. 8 (2002) 718-728
103. Piekarz R.L., Robey R., Sandor V., Bakke S., Wilson W.H., Dahmoush L., Kingma D.M., Turner M.L., Altemus R., and Bates S.E. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood 98 (2001) 2865-2868
104. Baylin S.B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2 Suppl. 1 (2005) S4-S11
105. Christiansen D.H., Andersen M.K., and Pedersen-Bjergaard J. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 17 (2003) 1813-1819
106. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., Jones P.A., and Lubbert M. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-aza-2′-deoxycytidine (decitabine) treatment. Blood 100 (2002) 2957-2964
107. Lubbert M. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr. Top Microbiol. Immunol. 249 (2000) 135-164
108. Venturelli S., Armeanu S., Pathil A., Hsieh C.J., Weiss T.S., Vonthein R., Wehrmann M., Gregor M., Lauer U.M., and Bitzer M. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma. Cancer 109 (2007) 2132-2141